Abstract
Argininemia is a rare hereditary disease due to a deficiency of hepatic arginase, which is the last enzyme of the urea cycle and hydrolyzes arginine to ornithine and urea. The onset of the disease is usually in childhood, and clinical manifestations include progressive spastic paraparesis and mental retardation. Liver involvement is less frequent and usually not as severe as observed in other UCDs. For this reason, and because usually there is a major neurological disease at diagnosis, patients with argininemia are rarely considered as candidates for OLT despite its capacity to replace the deficient enzyme by an active one. We report on long-term follow-up of two patients with argininemia. Patient 1 was diagnosed by the age of 20 months and despite appropriate conventional treatment progressed to spastic paraparesis with marked limp. OLT was performed at 10 years of age with normalization of plasmatic arginine levels and guanidino compounds. Ten years post-OLT, under free diet, there is no progression of neurological lesions. The second patient (previously reported by our group) was diagnosed at 2 months of age, during a neonatal cholestasis workup study. OLT was performed at the age of 7 years, due to liver cirrhosis with portal hypertension, in the absence of neurological lesions and an almost-normal brain MRI. After OLT, under free diet, there was normalization of plasmatic arginine levels and guanidino compounds. Twelve years post-OLT, she presents a normal neurological examination. We conclude that OLT prevents progressive neurological impairment in argininemia and should be considered when appropriate conventional treatment fails.
Competing interests: None declared
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Braga AC, Vilarinho L, Ferreira E, Rocha H (1997) Hyperargininemia presenting as persistent neonatal jaundice and hepatic cirrhosis. J Pediatr Gastroenterol Nutr 24:218–221
Brusilow SW, Horwich AL (2005) Urea cycle enzymes. In: Scriver CR et al (eds) Metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, Chap 85
Cardoso ML, Martins E, Vasconcelos R et al (1999) Identification of a novel R21X mutation in the liver-type arginase gene (ARG1) in four Portuguese patients with argininemia. Hum Mutation 14:355–356
De Deyn PP, Vanholder R, Eloot S, Glorieux G (2009) Guanidino compounds as uremic (neuro)toxins. Semin Dial 22(4):340–5
Hiramatzu M (2003) A role for guanidine compounds in the brain. Mol Cell Biochem 244:57–62
Knickmeyer RC, Gouttard S, Kang C, Evans D, Wilber K, Smith JK et al (2008) A structural MRI study of human brain development from birth to 2 years. Journal of Neuroscience 28(47):12176–12182
Marescau B, De Deyn PP, Lowenthal A, Qureshi IA, Antonozzi I, Bachmann C, Cederbaum SD, Cerone R, Chamoles N, Colombo JP et al (1990) Guanidino compound analysis as a complementary diagnostic parameter for hyperargininemia: follow-up of guanidino compound levels during therapy. Pediatr Res 27(3):297–303
Martins E, Santos Silva E, Vilarinho S, Saudubray JM, Vilarinho L (2011) Neonatal cholestasis: an uncommon presentation of hyperargininemia. J Inherit Metab Dis. 2011; DOI 10.1007/s10545- 010-9263-7.
Mizutani N, Hayakawa C, Ohya Y, Watanabe K, Watanabe Y, Mori A (1987) Guanidino compounds in hyperargininemia. Tohoku J Exp Med 153:197–205
Santos Silva E, Martins E, Cardoso ML, Barbot C, Vilarinho L, Medina M (2001) Liver transplantation in a case of argininemia. J inherit Metab Dis 24:885–887
Scaglia M, Lee B (2006) Clinical, biochemical and molecular spectrum of hyperargininemia due to arginase I deficiency. Am J Med Genet 142C:113–120
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Additional information
Communicated by: Jean-Marie Saudubray
Appendices
Concise Sentence Take-Home Message
OLT prevents progressive neurological impairment in argininemia and should be considered when appropriate conventional treatment fails.
Reference to Electronic Databases
Urea cycle disorders, argininemia, liver transplantation, neurological impairment.
Conflict of Interest
There is no conflict of interest.
Rights and permissions
Copyright information
© 2013 SSIEM and Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Silva, E.S., Cardoso, M.L., Vilarinho, L., Medina, M., Barbot, C., Martins, E. (2013). Liver Transplantation Prevents Progressive Neurological Impairment in Argininemia. In: Zschocke, J., Gibson, K., Brown, G., Morava, E., Peters, V. (eds) JIMD Reports - Volume 11. JIMD Reports, vol 11. Springer, Berlin, Heidelberg. https://doi.org/10.1007/8904_2013_218
Download citation
DOI: https://doi.org/10.1007/8904_2013_218
Received:
Revised:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-37327-5
Online ISBN: 978-3-642-37328-2
eBook Packages: MedicineMedicine (R0)